Literature DB >> 8118921

Further studies on the antioxidant role of pyrophosphate in model membranes.

G Cervato1, P Viani, P Gatti, R Cazzola, B Cestaro.   

Abstract

Our previous studies (G. Cervato et al., Chem. Phys. Lipids 56 (1990), 91-99) demonstrated that 100 microM pyrophosphate (PPi) inhibits Fe2+/ascorbate-induced peroxidation of arachidonic acid (AA) inserted in unilamellar liposomes (SUVs) of dipalmitoylphosphatidylcholine (DPPC), by chelating ferrous ions in the aqueous phase. In this work we demonstrate that the kinetics of AA peroxidation in DPPC SUVs are strongly affected by PPi, also at very low concentration (1 microM). In fact at low PPi concentration there is a longer lag-phase, while the maximum of thiobarbituric acid reactive substances (TBARS) is similar in both the presence and absence of 1 microM PPi. The lag-phase of peroxidation of AA in lysophosphatidylcholine (palmitoyl) (LysoPC) micelles is also prolonged. The AA peroxidation in membrane models without choline as the polar headgroup (dipalmitoylphosphatidylethanolamine (DPPE) SUVs, or Triton X-100 micelles), or in which AA is not free but esterified with glycerol (stearoyl-arachidonyl-phosphatidylcholine (SAPC)), is unaffected by the presence of 1 microM PPi.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8118921     DOI: 10.1016/0009-3084(93)90034-z

Source DB:  PubMed          Journal:  Chem Phys Lipids        ISSN: 0009-3084            Impact factor:   3.329


  1 in total

1.  Ferric pyrophosphate citrate administered via dialysate reduces erythropoiesis-stimulating agent use and maintains hemoglobin in hemodialysis patients.

Authors:  Ajay Gupta; Vivian Lin; Carrie Guss; Raymond Pratt; T Alp Ikizler; Anatole Besarab
Journal:  Kidney Int       Date:  2015-07-08       Impact factor: 10.612

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.